TNFSF10
Aliases:
This biomarker is also known as:- TRAIL
- APO2L
- tumor necrosis factor ligand superfamily member 10
- TNF-related apoptosis inducing ligand TRAIL
- tumor necrosis factor apoptosis-inducing ligand splice variant delta
- chemokine tumor necrosis factor ligand superfamily member 10
- Apo-2 ligand
- tumor necrosis factor (ligand) superfamily, member 10
- tumor necrosis factor (ligand) family, member 10
- TNF-related apoptosis-inducing ligand
- TL2
- Protein TRAIL
- CD253 antigen
- CD253
- TNFSF10
- Apo-2L
Description…
From NCBI Gene: The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. This protein binds to several members of TNF receptor superfamily including TNFRSF10A/TRAILR1, TNFRSF10B/TRAILR2, TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and possibly also to TNFRSF11B/OPG. The activity of this protein may be modulated by binding to the decoy receptors TNFRSF10C/TRAILR3, TNFRSF10D/TRAILR4, and TNFRSF11B/OPG that cannot induce apoptosis. The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2010]
Datasets
There are no datasets associated with this biomarker.
Attributes
| QA State: | Curated |
|---|---|
| Type: | Gene |
| HGNC Name: | TNFSF10 |
The following organs have data associated with this biomarker…
Attributes
| Phase: | 1 |
|---|---|
| QA State: | Under Review |
Organ-specific information for this biomarker is currently being annotated or is "under review". Logging in may give you privileges to view additional information. Contact the Informatics Center if you believe you should have access to this biomarker.
- History and molecular genetics of Lynch syndrome in family G: a century later.
- Differential diagnosis of a pelvic mass: improved algorithms and novel biomarkers.
- Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis.